A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2-Breast Cancer That Has Spread
Condition: Breast Cancer Interventions: Drug: nivolumab; Drug: ipilimumab; Drug: nab-paclitaxel Sponsor: Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials